Tracking TGTX? Get live short interest, options flow, and signals on ORTEX.Sign up free →

TG Therapeutics, Inc. (TGTX) short interest & options flow

NASDAQ

TG Therapeutics enters the final stretch of Q3 with an unusual split: the stock is holding near multi-year highs while short sellers are quietly rebuilding positions at a pace that puts short interest among the heaviest in the biotech sector. Short interest has climbed steadily to 21% of the free float — around 30.7 million shares — up roughly 2.3% on the week and 3.1% over the…

$60.75+1.33% 1d+7.64% 1w+11.90% 1mClose: 3 Nov 2026

Short interest % of float: High; Live SI on ORTEX →
Cost to borrow: Low and dropping; Live CTB on ORTEX →

Market cap: $8.62B
Next earnings: 9 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 4 Nov 2026

ORTEX chart of TG Therapeutics, Inc. (TGTX) share price and short interest (% of free float), six months to November 3, 2026

TGTX news and analysis

RSS

No long-form analysis yet for TGTX. Pulse alerts and the live data picture are available on ORTEX.

Open TGTX on ORTEX →

Want the live picture for TGTX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TGTX — free to start on ORTEX.

We value your privacy

TGTX news and analysis

Want the live picture for TGTX?